nikita
Pharmaranks rates Nikita 3.2/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Nikita (Pitavastatin Sodium) is a HMG-CoA reductase inhibitor used to treat Hypercholesterolemia, Hyperlipoproteinemias, Hypertriglyceridemia.
Pitavastatin Sodium · by Lupin
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Pitavastatin Sodium
- Drug class
- Hmg-Coa Reductase Inhibitor
- Form
- Tablet
- Strength
- Pitavastatin Sodium EQ 1MG Base · Pitavastatin Sodium EQ 2MG Base · Pitavastatin Sodium EQ 4MG Base
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Lupin
- Half-life
- about 12 hours (how long it stays in your system)
- What the pharmacy pays
- ~$38.04 for 30 — not your price
- FDA application
- NDA209875
- Availability
- Discontinued (per FDA)
How long does Pitavastatin Sodium stay in your body?
The elimination half-life of pitavastatin sodium is about 12 hours — the time it takes the body to clear about half of it. As a rule of thumb, a medicine is mostly gone after roughly 4 to 5 half-lives, though this varies from person to person with age and kidney or liver function. This is the mean plasma elimination (terminal) half-life the label reports in §12.3 for typical adults; the label gives no separate distribution-phase figure. Pitavastatin is not a prodrug. Its main metabolite is pitavastatin lactone (formed by UGT glucuronidation, with only minimal CYP450 involvement); the label does not describe the lactone as an active moiety and gives no half-life for it, so there is no known active metabolite that outlasts the parent. Liver impairment lengthens it: in the hepatic-impairment study, mean half-life was 15 hours with moderate impairment and 10 hours with mild impairment, versus 8 hours in the healthy volunteers of that same study (a lower figure than the ~12-hour overall mean, so treat these as within-study comparisons rather than absolute values). For kidney impairment the label reports higher exposure (AUC roughly 102% higher in moderate impairment, 86% higher in hemodialysis patients, 36% higher in severe impairment) but does not state a changed half-life. In adults 65 and older, Cmax and AUC were about 10% and 30% higher; again no half-life change is stated. This is not a drug-test detection window and not dosing guidance.
This is general information, not medical advice. It doesn’t tell you when a drug test would read negative (tests detect substances for different, often longer, windows) or when it’s safe to take another dose — ask your pharmacist or prescriber. Source: DailyMed — PITAVASTATIN CALCIUM (pitavastatin) tablet, film coated — FDA label, §12.3 Pharmacokinetics.
Drug class
How this class works, per HMG-CoA Reductase Inhibitors - StatPearls - NCBI Bookshelf.
May treat (source: NIH RxClass)
See how Nikita ranks — best-rated HMG-CoA reductase inhibitor for:
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Nikita treat?
- Nikita (Pitavastatin Sodium) may be used to treat hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How does Nikita work?
- Nikita is a HMG-CoA reductase inhibitor. Statins block HMG-CoA reductase, the key enzyme the liver uses to make cholesterol. With less cholesterol being produced, the liver pulls more LDL ("bad") cholesterol out of the blood, lowering overall blood cholesterol levels.
- How is Nikita rated?
- pharmaranks gives Nikita a composite score of 3.2 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- How much does Nikita cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $38.04 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins. Pharmacies pay less for a same-class option, Atorvaliq — about $0.92 on the same basis.
- Is there a coupon or discount for Nikita?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Nikita. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Nikita?
- Nikita is marketed by Lupin. You can see Lupin's full profile, rating, and other products on pharmaranks.
- Is Nikita a brand-name or generic drug?
- Nikita is a brand-name product with the active ingredient Pitavastatin Sodium.
- Is Nikita available over the counter?
- No. Nikita is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Nikita come in?
- Nikita is currently marketed as tablet, per the FDA's National Drug Code Directory.
- What class of drug is Nikita?
- Nikita is classified as hmg-coa reductase inhibitor, per the FDA's Established Pharmacologic Class.
- Is Nikita FDA-registered?
- Nikita is on record with the U.S. FDA under application number NDA209875. You can verify this on its official FDA label.
- Has Nikita been recalled by the FDA?
- Nikita has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Nikita safe?
- There's no single safe-or-not verdict. pharmaranks gives Nikita a recall-safety score of 64/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
crestor
Rosuvastatin Calcium
zocor
Simvastatin
lescol xl
Fluvastatin Sodium
pitavastatin calcium
Pitavastatin Calcium
lovastatin
Lovastatin
atorvaliq
Atorvastatin Calcium
Compare Nikita head-to-head
More HMG-CoA reductase inhibitor drugs
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
nikita
64/100